The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.
Illumina’s COVIDSeq Test enables qualitative detection of SARS-CoV-2 RNA from respiratory specimens.
These countries have been more successful with managing the virus than the United States and the European Union.
COVID-19 requires us to rethink our current device disinfection procedure.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
The idea of harnessing the body’s response to heal and defend is no longer the stuff of science fiction.
The company developed the device as an alternative to reusable duodenoscopes, enabling the use of a new and sterile product for each procedure.
Researchers have developed a test that may be more sensitive that currently available lab tests.
Each year, more than 250,000 Americans die from the common and deadly condition.
It’s time to embrace new technology and promote standardization to raise best practice protocols.